<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Heinrich</forename><surname>Kovar</surname></persName>
							<email>heinrich.kovar@ccri.at</email>
							<affiliation key="aff0">
								<orgName type="institution">Children&apos;s Cancer Research Institute</orgName>
								<address>
									<addrLine>St. Anna Kinderkrebsforschung</addrLine>
									<postCode>1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
							<affiliation key="aff0">
								<orgName type="institution">Children&apos;s Cancer Research Institute</orgName>
								<address>
									<addrLine>St. Anna Kinderkrebsforschung</addrLine>
									<postCode>1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">801B9BC83DB6F3FB77EDF1DB175B1CC8</idno>
					<idno type="DOI">10.1155/2011/837474</idno>
					<note type="submission">Received 2 September 2010; Revised 20 October 2010; Accepted 1 November 2010</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-07-02T08:59+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=0, consolidateHeader=0, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=false, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], sentenceSegmentation=false, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>FUS, EWS, and TAF15 form the FET family of RNA-binding proteins whose genes are found rearranged with various transcription factor genes predominantly in sarcomas and in rare hematopoietic and epithelial cancers. The resulting fusion gene products have attracted considerable interest as diagnostic and promising therapeutic targets. So far, oncogenic FET fusion proteins have been regarded as strong transcription factors that aberrantly activate or repress target genes of their DNA-binding fusion partners. However, the role of the transactivating domain in the context of the normal FET proteins is poorly defined, and, therefore, our knowledge on how FET aberrations impact on tumor biology is incomplete. Since we believe that a full understanding of aberrant FET protein function can only arise from looking at both sides of the coin, the good and the evil, this paper summarizes evidence for the central function of FET proteins in bridging RNA transcription, processing, transport, and DNA repair.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>The Strange Case of Dr. Jekyll and Mr. Hyde, a novel by the Scottish poet Robert Luis <ref type="bibr">Stevenson (1850</ref><ref type="bibr">Stevenson ( -1894))</ref>, screened multiple times worldwide, describes the struggle between the good and evil sides of one individual <ref type="bibr" target="#b0">[1]</ref>. At daylight, Dr. Jekyll is an honorable member of the society, but when the light fades he turns into an evil beast. The coexistence of two faces of one individual has inspired more than poetry and psychology. The question of which circumstances favor the surfacing of one or the other and how it may be influenced is relevant to all areas of life, including economy, technology and medicine. Cancer unravels the "Hyde" side of genes and their biology, but we can learn about how to tame fierce Mr. Hyde by understanding the Dr. Jekyll behind, the normal function of cancer genes.</p><p>FET (FUS, EWS, TAF15) proteins are a ubiquitously expressed family of similarly structured proteins predominantly localizing to the nuclear <ref type="bibr" target="#b1">[2]</ref>. FET genes have attracted broad attention since all known members are found involved in deleterious genomic rearrangements with transcription factor genes in a variety of human sarcomas and acute leukemias. Chimeric FET proteins are considered and mostly studied as aberrant transcription factors. This paper aims at summarizing the good sides of FET proteins and looking at the characteristics of aberrant FET proteins as Dr. Jekyll's second face which surfaces only upon gene rearrangement or mutation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Dr. Jekyll</head><p>2.1. The FET Family of Proteins. The prototype FET protein EWS was identified in 1992 as the gene product encoded by the Ewing's sarcoma breakpoint region 1 (EWSR1) on chromosome 22q12 constituting the first identified member of a family of putative RNA-binding proteins <ref type="bibr" target="#b2">[3]</ref>, including also FUS/TLS/Pigpen/hnRNP P2 <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>, TAF15/hTAF II 68/TAF2N/RPB56 <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9]</ref>, and Drosophila Cabeza/SARFH <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref> that share distinct structural characteristics (Figure <ref type="figure">1</ref>). This protein family is frequently referred to as the FET (previously TET) (FUS/TLS, EWS, TAF15) family of proteins. Our restricted knowledge about the molecular functions of FET proteins derives mainly from protein interaction studies which identified more than 30 associated proteins mostly as part of protein/RNA complexes <ref type="bibr" target="#b11">[12]</ref> (Table <ref type="table">1</ref>). Of note, pull-down experiments using EWS as bait revealed that all three FET proteins interact with each Sarcoma other and are therefore likely to be part of the very same protein complexes. As demonstrated for EWS, the association with most interacting proteins depends on the presence of RNA and is destroyed upon RNaseA treatment (Table <ref type="table">1</ref>). The functional roles of interacting proteins suggest a general bridging role for FET proteins coupling RNA transcription, processing, transport, and DNA repair.</p><p>2.2. RNA Binding of FET Proteins. Several functional FET domains were defined (see Figure <ref type="figure">1</ref>): the N-terminal domain is largely composed of a highly repetitive primary sequence containing multiple copies of a degenerate hexapeptide repeat motif similar to the C-terminal domain of RNA polymerase II. The C-terminal domain (CTD) contains a conserved nuclear import and retention signal (C-NLS) <ref type="bibr" target="#b12">[13]</ref>, a putative zinc-finger domain, and a conserved RNA recognition motif (RRM) flanked by 3 arginine-glycineglycine (RGG) boxes <ref type="bibr" target="#b13">[14]</ref> compatible with RNA binding of FET proteins. FUS has been demonstrated to bind preferentially to GGUG-containing RNAs <ref type="bibr" target="#b14">[15]</ref>. EWS might have similar sequence specificity since it was demonstrated to bind strongly to both poly G and poly U, but not to poly A and poly C RNA, homopolymers <ref type="bibr" target="#b15">[16]</ref>. Although it is only the zinc finger domain of FUS that makes physical contact with the GGUG motif, all three RGG boxes together with the RRM contribute to this activity <ref type="bibr" target="#b14">[15]</ref>. Intriguingly, a recent study identified strong binding of FUS to human telomeric RNA <ref type="bibr" target="#b16">[17]</ref> and to small low-copy-number RNAs tethered to the promoter of cyclin D1 <ref type="bibr" target="#b17">[18]</ref>. Nothing is known about the RNA binding specificity TAF15.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">A Role for FET</head><p>Proteins in RNA Transcription. The FET N-terminal domain (NTD) resembles the activation domain of certain transcription factors such as SP-1 rich in glutamine and proline residues. When fused to a DNA-binding domain (DBD), as is the case in oncogenic FET derivatives, the NTD strongly activates reporter gene activity in a DNA-bindingdependent way <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref>. The critical determinants for this transactivation activity are dispersed throughout the NTD <ref type="bibr" target="#b23">[24]</ref>, which is intrinsically disordered <ref type="bibr" target="#b24">[25]</ref>. It is comprised of a variable number of a degenerate hexapeptide repeat motif (DHR) with the consensus SYGQQS, with homologies to the C-terminus of RNA polymerase II <ref type="bibr" target="#b2">[3]</ref>. Mutation analysis of the EWS NTD revealed a critical dependence of the transactivation activity on the aromatic side chain of the conserved tyrosine residue present in the DHR <ref type="bibr" target="#b20">[21]</ref>.</p><p>The function of the NTD in the context of germline FET proteins remains largely unexplored. When included into artificial FET-DBD fusion proteins, the CTD inhibited transcriptional activation by the NTD <ref type="bibr" target="#b25">[26]</ref>. More recent data demonstrated that the RGG motifs of the FET-CTD repress a range of transcriptional activation domains <ref type="bibr" target="#b26">[27]</ref>. The context-dependent difference in the transactivation potential of the NTD might be explained by different structures and accessibility of the NTD for protein interactions in the presence and absence of the CTD <ref type="bibr" target="#b27">[28]</ref>. Protein interaction between the very N-terminus of EWS and the RNA PolII holoenzyme component hsRPB7 was only observed for EWS-FLI1 and C-terminal truncated EWS, while interaction with hsRPB5 and hsRPB3 was restricted to germline EWS <ref type="bibr" target="#b28">[29,</ref><ref type="bibr" target="#b29">30]</ref>. EWS has been reported to support CREBbinding-protein-(CBP/p300-) dependent activation by the transcription factors HNF-4 and OCT-4 <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b31">32]</ref> which is inhibited by the EWS-interacting protein STRAP (serinethreonine kinase receptor-associated protein) <ref type="bibr" target="#b32">[33]</ref>. Similarly, FUS acts as a positive cofactor for NFkappaB-mediated transcription <ref type="bibr" target="#b33">[34]</ref>. In contrast, EWS repressed BRN3Adependent transcription <ref type="bibr" target="#b34">[35]</ref>.</p><p>All three FET proteins were found to associate with RNA polymerase II and subpopulations of the TF II D complex, respectively <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b35">36]</ref>. Consistent with an evolutionary conserved role of FET proteins in RNA transcription, SARFH was found to be associated with transcribed chromatin in Drosophila <ref type="bibr" target="#b9">[10]</ref>. Interactions of the NTD with various transcription factors were described (FUS with steroid, thyroid hormone, and retinoid receptors <ref type="bibr" target="#b36">[37]</ref>, EWS with Brn3A and via CBP/p300 with HNF4 and OCT4 <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b37">38]</ref>). Interestingly, EWS and FUS were found to bind directly to the proximal elements of the macrophage-specific promoter of the CSF-1 receptor (CSF1R) gene and also to high-affinity sites recognized by myeloid zinc finger protein 1 (Mzf1) suggesting a role in transcriptional start site selection of TATA-less promoters <ref type="bibr" target="#b38">[39]</ref>.</p><p>Besides their role in RNA-polymerase-II-mediated transcription, the recent finding of FUS repressing RNA polymerase III-dependent transcription of small untranslated RNAs implies a more general role for FET proteins in the orchestration of the transcriptome <ref type="bibr" target="#b39">[40]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>2.4.</head><p>A Role for FET Proteins in mRNA Maturation. The RNAbinding specificity of FUS for the GGUG motif found in 5 splice sites suggests a role in RNA processing. EWS and FUS were identified within the same RNA-splicing complex together with polypyrimidine-tract-binding-proteinassociated factor (PSF) <ref type="bibr" target="#b40">[41]</ref>. In addition, EWS and FUS associate with a variety of splicing factors such as U1C, SR, SF1, and YB1 <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref>. Further, EWS NTD and FUS bind to novel RNA helicases <ref type="bibr" target="#b47">[48,</ref><ref type="bibr" target="#b48">49]</ref>. Moreover, interaction of the EWS NTD with BARD1, a protein playing an important role in the inhibition of RNA maturation at sites of stalled transcription upon DNA damage, was reported <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref>. Together, these results suggest that FET proteins couple RNA transcription to processing. The mechanism and specificity of this activity remain largely unknown.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5.">A Role for FET Proteins in the Processing of Small</head><p>Noncoding RNAs. EWS was recently identified in a protein complex with the nuclear RNase III DROSHA <ref type="bibr" target="#b53">[54]</ref>. While DROSHA is known to be central to the cleavage of the premicro-RNA (miRNA) precursor from the primary miRNA transcript thereby initiating miRNA processing and transport to the cytoplasm, evidence for a functional role of the EWS containing DROSHA complex is missing. Therefore, a general role for EWS in the metabolism of noncoding RNAs remains to be demonstrated. Since about a quarter of miRNA genes are encoded in the introns of protein-coding</p><p>Sarcoma 3 DHR R7BD ZFM1(IQ) RGG1 RGG2 RGG3 RRM Z NLS aa 1 82 228 301 361 448 524 544 639 656 EAD RBD Fusion region EWS NTD: N-terminal domain C-terminal domain CTD: R7BS: ZFM1(IQ): IQ domain binding to ZMF1 RGG1, 2, 3: Arginine/Glycine/Glycineboxes 1, 2, 3 RRM: RNA recognition motif Z: Zinc finger domain NLS: Nuclear localization signal EAD: EWS activation domain RBD: Fusion region: Domain disrupted by fusion to transcription factor moieties when EWS is rearranged DHR: Degenerate hexapeptide repeats NTD CTD R7BS: RPB7-binding domain RBD: RNA-binding domain Figure 1: Structure of the prototype FET protein EWS.</p><p>genes <ref type="bibr" target="#b54">[55]</ref>, it is intriguing to speculate that EWS links not only transcription to RNA splicing but also to the generation of miRNAs from gene introns. This, so far hypothetical, activity may gain importance in the light of frequent negative posttranscriptional regulation of miRNA processing at the DROSHA level in cancer <ref type="bibr" target="#b55">[56]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>2.6.</head><p>A Role for FET Proteins in RNA Transport. Consistent with their proposed function in gene regulation, FET proteins are mostly nuclear, localizing to inclusions such as the coiled body and the nucleolus (demonstrated for EWS, FUS, and pigpen in <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b56">57,</ref><ref type="bibr" target="#b57">58]</ref>). There is also evidence that FET proteins shuttle between the nucleus and the cytoplasm raising the possibility that they play a role in RNA transport <ref type="bibr" target="#b58">[59,</ref><ref type="bibr" target="#b59">60]</ref>. In mouse hippocampal neurons, FUS is localized to neuronal dendrites and, upon activation, translocate to the spines, where local translation takes place, carrying along specific mRNA transcripts <ref type="bibr" target="#b60">[61,</ref><ref type="bibr" target="#b61">62]</ref>. This finding implicates FET proteins in localizing cytoplasmic determinants for the local control of protein synthesis and secretion, at least in neurons.</p><p>For EWS, RNA binding, subcellular localization, and consequently transcriptional activity have been found to be regulated by extensive asymmetric dimethylation of the RGG motifs, mediated by protein arginine methyltransferases 1 and 8 (PRMT1, PRMT8) <ref type="bibr" target="#b66">[67]</ref><ref type="bibr" target="#b67">[68]</ref><ref type="bibr" target="#b68">[69]</ref><ref type="bibr" target="#b69">[70]</ref>, which likely impacts on self-association of intact EWS required for nuclear localization <ref type="bibr" target="#b70">[71,</ref><ref type="bibr" target="#b71">72]</ref>. Extensively methylated EWS has even been identified on the cell surface <ref type="bibr" target="#b72">[73]</ref>. So far, the functional relevance of these findings has yet to be determined.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.7.">A Role for FET Proteins in Genome</head><p>Surveillance and DNA Repair. FUS deficiency in mice resulted in defective B-lymphocyte development and activation, high levels of chromosomal instability, and perinatal death <ref type="bibr" target="#b73">[74]</ref>. EWS knock-out mice also displayed disrupted B-cell development and were extremely sensitive to ionizing radiation. Together with a defect in homologous recombination impairing meiosis and the observation of premature senescence of embryonic fibroblasts, these results suggest a role for EWS in recombination repair <ref type="bibr" target="#b74">[75]</ref>. In the zebrafish, silencing of EWS genes during embryogenesis led to mitotic defects followed by p53-dependent apoptosis <ref type="bibr" target="#b75">[76]</ref>.</p><p>Consistent with the phenotype of FET deficiency in genetically modified mice, the interaction of EWS (and EWS-FLI1) with the BRCA1-associated ring finger domain protein BARD1 may point to a role of FET proteins in DNA doublestrand break repair <ref type="bibr" target="#b52">[53]</ref>. This hypothesis is strengthened by high genomic instability in FUS knock-out mice <ref type="bibr" target="#b73">[74]</ref> and radiation sensitivity and impaired homologous recombination in EWS knockouts <ref type="bibr" target="#b74">[75]</ref>. The recently discovered homologous DNA-strand-pairing activity of all four FET proteins may functionally contribute to this role <ref type="bibr" target="#b76">[77]</ref>.</p><p>Intriguingly, the RNA binding activity of FUS was reported to act as a sensor for DNA damage and to elicit transcriptional repression; as exemplified for cyclin D (CCND1) promoter regulation, DNA damage was demonstrated to induce the expression of single-stranded, low-copy-number ncRNA transcripts tethered to the 5 regulatory regions of CCND1 which recruit FUS and allosterically modify it to bind to and repress CREB-binding protein (CBP) and p300 histone acetyltransferase activities <ref type="bibr" target="#b17">[18]</ref>.</p><p>Activation of gene transcription by many, if not all, sequence-specific transcription factors requires DNAtopoisomerase-II-beta-dependent, transient, site-specific dsDNA break formation <ref type="bibr" target="#b77">[78]</ref>. One may speculate that the proposed role of FET proteins in recombination repair is linked to their association with transcription initiation complexes at promoter regions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sarcoma</head><p>Table 1: EWS interacting proteins: * not bound by methylated EWS; * * not bound by methylated EWS upon RNaseA treatment.</p><p>RNase A sensitive hnRNP A0 <ref type="bibr" target="#b11">[12]</ref> Pre-mRNA processing, RNA metabolism, RNA transport hnRNP A1 <ref type="bibr" target="#b11">[12]</ref> Pre-mRNA processing, RNA metabolism, and RNA transport may modulate splice site selection hnRNP A2B1 <ref type="bibr" target="#b11">[12]</ref> Pre-mRNA processing, RNA metabolism, RNA transport hnRNP A3 <ref type="bibr" target="#b11">[12]</ref> Regulation of age-related gene expression, binds to telomeric RNA hnRNP A/B <ref type="bibr" target="#b11">[12]</ref> Binds to multiprotein editosome complex hnRNP A18 * <ref type="bibr" target="#b11">[12]</ref> Stabilization of transcripts, genotoxic stress response, translational activator, binds to 3 UTR hnRNP D0 <ref type="bibr" target="#b11">[12]</ref> Regulation of mRNA stability hnRNP F <ref type="bibr" target="#b11">[12]</ref> Binds G-rich sequences hnRNP G <ref type="bibr" target="#b11">[12]</ref> Regulation of splice site selection, DNA double-strand break repair hnRNP H <ref type="bibr" target="#b11">[12]</ref> Pre-mRNA alternative splicing regulation hnRNP H2 <ref type="bibr" target="#b11">[12]</ref> Involved in Fabray disease and X-linked agammaglobulinemia hnRNP H3 <ref type="bibr" target="#b11">[12]</ref> Early heat shock-induced splicing arrest hnRNP Q <ref type="bibr" target="#b11">[12]</ref> RNA stability, translationally coupled mRNA turnover Small nuclear ribonucleoprotein Sm D3 <ref type="bibr" target="#b11">[12]</ref> Pre-mRNA splicing and small nuclear ribonucleoprotein biogenesis, histone 3 -end processing U1 small nuclear ribonucleoprotein A * <ref type="bibr" target="#b11">[12]</ref> First snRNP to interact with pre-mRNA for the subsequent binding of U2 snRNP and the U4/U6/U5 tri-snRNP Splicing factor, arginine/serine-rich 1 * <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b43">44]</ref> Accuracy of splicing and regulation of alternative splicing Splicing factor, arginine/serine-rich 3 * <ref type="bibr" target="#b11">[12]</ref> Putative proliferation-/maturation-associated RNA processing Splicing factor, arginine/serine-rich 9 * <ref type="bibr" target="#b11">[12]</ref> Constitutive splicing RRM containing coactivator activator <ref type="bibr" target="#b11">[12]</ref> Activation/modulation of nuclear receptors Tubulin alpha ubiquitous chain <ref type="bibr" target="#b11">[12]</ref> Scaffold for cell shape and organelle movement</p><p>Vimentin 1  Organizer of a number of critical proteins involved in attachment, migration, and cell signaling RNase insensitive Protein arginine N methyltransferase 1 <ref type="bibr" target="#b11">[12]</ref> Epigenetic regulation, signal transduction, DNA repair Protein arginine N-methyltransferase 8 <ref type="bibr" target="#b62">[63]</ref> Localized at cell membrane hnRNP M <ref type="bibr" target="#b11">[12]</ref> Splicing, selective recycling of immature GlcNAc-bearing, thyroglobulin molecules, potentially involved in signalling hnRNP U <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b42">43]</ref> Binds double-and single-stranded RNA and DNA, binds pre-mRNA FUS * * <ref type="bibr" target="#b11">[12]</ref> This review TAF15 * <ref type="bibr" target="#b11">[12]</ref> This review EWS * <ref type="bibr" target="#b63">[64]</ref> This review RNA-dependent helicase p68 (DDX5) <ref type="bibr" target="#b11">[12]</ref> RNA-dependent ATPase, alteration of RNA secondary structure in splicing and translation initiation RNA-dependent helicase p72 (DDX17) <ref type="bibr" target="#b11">[12]</ref> RNA-dependent ATPase, alteration of RNA secondary structure in splicing, and translation initiation ATP-dependent RNA helicase A <ref type="bibr" target="#b11">[12]</ref> ATP-dependent unwinding of double-stranded RNA and DNA-RNA complexes, transcriptional regulation ATP-dependent RNA helicase DHX36 * <ref type="bibr" target="#b11">[12]</ref> Deadenylation and decay of mRNAs with 3 -UTR AU-rich elements Elongation factor EF1 gamma <ref type="bibr" target="#b11">[12]</ref> Translation elongation, role in anchoring the translational complex to other cellular components Elongation factor EF1 alpha <ref type="bibr" target="#b11">[12]</ref> Translation elongation, promotes aminoacyl-tRNA binding to ribosome Dead box protein 3 X (DDX3X) * <ref type="bibr" target="#b11">[12]</ref> ATP-dependent RNA helicase Tubuline beta-2 chain <ref type="bibr" target="#b11">[12]</ref> Scaffold for cell shape and organelle movement RNA dependence unknown: RBP3 <ref type="bibr" target="#b28">[29]</ref> RNA Polymerase II component TAF5 <ref type="bibr" target="#b28">[29]</ref> General transcription factor TF II D component TAF7 <ref type="bibr" target="#b28">[29]</ref> General transcription factor TF II D component</p><p>5805, 2011, 1, Downloaded from <ref type="url" target="https://onlinelibrary.wiley.com/doi/10.1155/2011/837474">https://onlinelibrary.wiley.com/doi/10.1155/2011/837474</ref>, Wiley Online Library on [04/03/2025]. See the Terms and Conditions (<ref type="url" target="https://onlinelibrary.wiley.com/terms-and-conditions">https://onlinelibrary.wiley.com/terms-and-conditions</ref>) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License Table 1: Continued.</p><p>RNase A sensitive TAF11 <ref type="bibr" target="#b28">[29]</ref> General transcription factor TF II D component TAF13 <ref type="bibr" target="#b28">[29]</ref> General transcription factor TF II D component Brn-3a <ref type="bibr" target="#b34">[35]</ref> Transcription factor SF1 <ref type="bibr" target="#b46">[47]</ref> Splicing factor YB1 <ref type="bibr" target="#b41">[42]</ref> Splicing factor Survival motor neuron protein * <ref type="bibr" target="#b64">[65]</ref> Essential role in spliceosomal snRNP assembly in the cytoplasm and is required for pre-mRNA splicing in the nucleus Serine threonine kinase receptor (STRAP) <ref type="bibr" target="#b32">[33]</ref> Inhibits transforming growth factor beta (TGF-beta) signaling BARD1 <ref type="bibr" target="#b52">[53]</ref> DNA repair, mRNA maturation Pyk2 <ref type="bibr" target="#b65">[66]</ref> Tyrosine kinase, signal transduction</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Mr. Hyde</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">The Role of FUS in Neurodegenerative</head><p>Disease. Point mutations of FUS have recently been found in a subset of patients with familial amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder destroying motoneurons <ref type="bibr" target="#b78">[79,</ref><ref type="bibr" target="#b79">80]</ref>. Previously, this disease has been associated with mutations in either superoxide dismutase 1 (SOD1) or TDP43 (43 kDa TAR DNA-binding domain protein). TDP43 is an essential nuclear RNA-binding protein that participates in transcriptional repression, exon splicing inhibition, and mRNA stabilization. The convergent phenotypes associated with FUS and TDP43 mutations suggest that they are part of the same machinery. In fact, TDP-43 and FUS were demonstrated to function in a biochemical complex to modulate expression of HDAC6, a recently identified mRNA substrate of TDP-43 <ref type="bibr" target="#b80">[81]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">The Oncogenic Function of FET Fusion Protein.</head><p>The predominant type of FET gene aberrations is that of fusions to various transcription factor genes by which the FET RNAbinding domain is replaced by the DNA-binding domain of the transcription factor (Table <ref type="table" target="#tab_3">2</ref>). FET fusion proteins are capable of transforming cells in culture dependent on the cellular context. EWS-ETS fusions, for example, transform NIH3T3 and bone-marrow-derived mesenchymal progenitor cells, but not human or rat primary fibroblasts, mouse embryonic stem cells, or embryonic fibroblasts <ref type="bibr" target="#b101">[102,</ref><ref type="bibr" target="#b102">103]</ref>. The phenotype of tumors obtained in immunodeficient mice after transplantation of EWS-ETS-transformed NIH3T3 cells clearly differs from that obtained after transformation with other EWS-transcription factor fusions and resembles that of Ewing's sarcoma <ref type="bibr" target="#b103">[104,</ref><ref type="bibr" target="#b104">105]</ref>. In the xenograft model, the amino terminal portion of EWS, as well as FUS (and presumably also TAF15), is functionally interchangeable in the fusion protein, while the transcription factor moiety determines the tumor phenotype <ref type="bibr" target="#b6">[7]</ref>. Functional interchangeability of the FET-NTD is also reflected in human sarcomas: both EWS-CHOP and FUS-CHOP characterize myxoid liposarcoma <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b93">94]</ref>, and EWS-NR4A3 and TAF15-NR4A3 are found in extraskeletal myxoid chondrosarcoma <ref type="bibr" target="#b105">[106]</ref>. It was therefore hypothesized that FET fusion proteins affect differentiation programs by aberrant regulation of genes specifically recognized by the transcription factor DNA-binding moiety.</p><p>The best studied example in this respect is EWS-FLI1 in Ewing's sarcoma family tumors (ESFT). Using experimental knockdown of EWS-FLI1 in ESFT cell lines and comparison to primary tumours and normal tissues, signatures of the chimeric transcription factor on the ESFT transcriptome were defined <ref type="bibr" target="#b124">[125,</ref><ref type="bibr" target="#b129">130,</ref><ref type="bibr" target="#b130">131</ref>]. An almost equal number of genes were found activated and repressed by EWS-FLI1. Of the approximately 600 to 800 significantly dysregulated genes, only a fraction is directly bound by EWS-FLI1 and many EWS-FLI1 bound genes do not show aberrant regulation (our unpublished observations). Over the years a number of directly EWS-FLI1-regulated genes have been characterized in ESFT (Table <ref type="table">3</ref>). It is interesting to note that almost all attempts to experimentally restore the presumed "normal" expression pattern of these targets in ESFT cell lines (by ectopic reexpression of EWS-FLI1 repressed genes and knockdown of EWS-FLI1-activated genes) resulted in reduced tumor cell growth in vitro and/or reduced tumorigenicity in vivo and in several cases enhanced chemosensitivity (Table <ref type="table">3</ref>). These results suggest that directly EWS-FLI1-regulated genes play essential roles in the establishment and/or the maintenance of the malignant phenotype of ESFT.</p><p>Functional annotation of EWS-FLI1-regulated genes revealed that activated genes primarily annotate to proliferation-associated functions, while genes involved in developmental and differentiation processes are predominantly repressed <ref type="bibr" target="#b130">[131]</ref>, suggesting that EWS-FLI1 suppresses differentiation of the enigmatic ESFT precursor cell. In fact, sustained silencing of EWS-FLI1 restores the potential of ESFT cells to differentiate along adipogenic, neuronal, and osteogenic lineages <ref type="bibr" target="#b131">[132]</ref>, a feature shared with mesenchymal stem cells (MSC). Conversely, ectopic EWS-FLI1 expression blocks the differentiation potential of MSC and imposes an ESFT-like phenotype on them <ref type="bibr" target="#b102">[103,</ref><ref type="bibr" target="#b132">133,</ref><ref type="bibr" target="#b133">134]</ref>. Consistent with the role of EWS-FLI1 in the disruption of developmental differentiation processes is the finding of skeletal malformations in mice expressing transgenic EWS-FLI1 in the mesenchymal lineage <ref type="bibr" target="#b134">[135]</ref>. Similarly, the FUS-ERG fusion found in human myeloid leukemia with the t(16;21) translocation was demonstrated to block terminal Sarcoma differentiation of and confer a growth advantage to human myeloid progenitor cells <ref type="bibr" target="#b135">[136]</ref>. Consistent with early in vitro data <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref>, activated genes showed an enrichment of ETS-binding motifs in their promoters while this motif was underrepresented in repressed genes <ref type="bibr" target="#b130">[131]</ref>. This result suggests that gene repression regulating differentiation genes might be mediated by indirect mechanisms. One such mechanism involved in blocking osteogenic differentiation is interaction and interference of EWS-FLI1 with the master regulator of bone and cartilage development, RUNX2 <ref type="bibr" target="#b136">[137]</ref>. RUNX2 was demonstrated to bind also to intact EWS and FUS <ref type="bibr" target="#b137">[138]</ref>. A number of different transcription factor binding motifs overrepresented in the promoters of EWS-FLI1-repressed genes may be indicative of other protein interactions that remain to be defined. Additional mechanisms of gene repression downstream of EWS-FLI1 involve the activity of transcriptional repressors whose expression is upregulated by EWS-FLI1 such as NKX2.2 <ref type="bibr" target="#b138">[139]</ref> or the epigenetic modifier EZH2 <ref type="bibr" target="#b119">[120]</ref> and the regulation of microRNAs <ref type="bibr" target="#b139">[140]</ref>. An alternative intriguing mechanism may involve the binding of EWS-FLI1 to microsatellites outside of promoter regions even at distances of several megabases from the transcriptional start sites <ref type="bibr" target="#b140">[141]</ref><ref type="bibr" target="#b141">[142]</ref><ref type="bibr" target="#b142">[143]</ref>. While these elements can activate transcription when juxtaposed to a promoter, their activity and mechanism of action from distant sites remains elusive.</p><p>Interestingly, there is evidence that EWS and EWS-FLI1 form a fatal liaison in that genes targeted by the FLI1 DNAbinding domain encode for proteins that interact with the EWS N-terminal domain in both the intact EWS protein and the chimeric protein. This is the case for NR0B1, a protein known to form large complexes with the stem cell factors OCT3 and OCT4, as well as EWS <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b143">144,</ref><ref type="bibr" target="#b144">145]</ref>. Intriguingly, the translocation t(6;22)(p21;q12) found in some undifferentiated sarcomas and neoplasms of skin and salivary glands directly fuses OCT4 to EWSR1. Among EWS-FLI1-repressed genes is also hsa-mir-145, a microRNA targeting OCT4 and other stem cell factors and feeding back on EWS-FLI1 expression <ref type="bibr" target="#b132">[133]</ref>. These findings provide evidence that EWS and EWS-FLI1 form a functional network in the regulation of tumor cell stemness.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">A Transcription-Independent Role for the EWS-FLI1</head><p>Fusion Protein. The first indication that malignant transformation by FET fusion proteins may involve functions other than direct transcriptional activation of target genes recognized by the DBD came from functional dissection of the EWS-FLI1 fusion protein in NIH3T3 transformation assays. These studies suggested that the minimal transforming and the minimal transcriptional activation domains can be separated from each other <ref type="bibr" target="#b145">[146]</ref>. Specifically, the 83 Nterminal amino acids were sufficient to transform NIH3T3</p><p>Table 3: Validated direct EWS-FLI1 target genes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EWS-FLI1 activated genes Consequences of target suppression</head><p>Id2 <ref type="bibr" target="#b106">[107]</ref> Not known GLI1 <ref type="bibr" target="#b107">[108]</ref> Reduced anchorage independent growth [109] VEGF <ref type="bibr" target="#b109">[110]</ref> Decreased osteolysis <ref type="bibr" target="#b110">[111]</ref> STYXL1 <ref type="bibr" target="#b111">[112]</ref> Notknown PLD2 <ref type="bibr" target="#b112">[113]</ref> Inhibition of PDGF BB signalling PTPL1 <ref type="bibr" target="#b113">[114]</ref> Reduced growth and increased chemosensitivity <ref type="bibr" target="#b113">[114]</ref> CAV1 <ref type="bibr" target="#b114">[115]</ref> Reduced anchorage independent growth, reduced tumorigenicity GSTM4 <ref type="bibr" target="#b115">[116]</ref> Abrogation of oncogenic transformation, increased chemosensitivity [116] NR0B1 <ref type="bibr" target="#b116">[117,</ref><ref type="bibr" target="#b117">118]</ref> Abrogation of oncogenic transformation <ref type="bibr" target="#b118">[119]</ref> EZH2 <ref type="bibr" target="#b119">[120]</ref> Reduced anchorage independent growth, reduced tumorigenicity [120] AURKA, AURKB <ref type="bibr" target="#b120">[121]</ref> Not known</p><p>Tenascin C <ref type="bibr" target="#b121">[122]</ref> Not known EWS-FLI1 repressed genes Consequences of target restoration TGFBR2 <ref type="bibr" target="#b122">[123]</ref> Loss of tumorigenicity [123] CDKN1A <ref type="bibr" target="#b123">[124]</ref> Inhibition of cell growth <ref type="bibr" target="#b123">[124]</ref> IGFBP3 <ref type="bibr" target="#b124">[125]</ref> Inhibition of cell growth and motility [126] FOXO1 <ref type="bibr" target="#b126">[127]</ref> Notknown DKK1 <ref type="bibr" target="#b127">[128,</ref><ref type="bibr" target="#b128">129]</ref> Decreased tumorigenicity <ref type="bibr" target="#b127">[128]</ref> cells when fused to the FLI1 DBD. Protein interactions with this domain were found to be context dependent <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref>.</p><p>In addition, residual transforming activity of EWS-FLI1 was retained even when the FLI1-DBD was destroyed, suggesting a DNA-binding-independent function for the oncogenic fusion protein <ref type="bibr" target="#b146">[147,</ref><ref type="bibr" target="#b147">148]</ref>. Also, EWS-FLI1 was shown to inhibit the CBP-dependent transcriptional activity of the retinoid acid (RA) receptor RXR desensitizing cells to the differentiation and apoptosis inducing activity of RA by a mechanism unrelated to DNA binding <ref type="bibr" target="#b37">[38]</ref>.</p><p>Protein interaction studies revealed that the EWS-NTD and the FUS-NTD in the context of their oncogenic fusion proteins communicate with the same RNA processing factors as in germline EWS <ref type="bibr">[42-44, 46, 47, 53]</ref> but interfere with serine arginine protein (SR) and YB1-mediated splicing <ref type="bibr" target="#b41">[42,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b44">45]</ref>. In addition, it was demonstrated that EWS-FLI1, but not EWS, interfered with heterogeneous nuclear ribonucleoprotein A1-dependent 5 splice site selection in an in vivo E1A splicing assay <ref type="bibr" target="#b148">[149]</ref>. This result might possibly be explained by a dominant negative effect of EWS-FLI1 on the RNA processing function of EWS that remains to be investigated. In fact, we have previously demonstrated that EWS-FLI1 can interact with its germline counterpart <ref type="bibr" target="#b63">[64]</ref>. Importantly, mutational analysis of EWS-FLI1 revealed that the ability to affect pre-mRNA splicing coincided with transforming activity <ref type="bibr" target="#b148">[149]</ref>. These results suggest a role for EWS-FLI1 in RNA processing. However, this role may not be regarded as transcription independent. A recent study of transcriptional elongation of the direct EWS-FLI1 target gene cyclin D1 (CCND1) revealed that both EWS and EWS-FLI1 stimulate transcription of the gene, but elongation by EWS-FLI1 is significantly slowed down in comparison to EWS. As a result, expression of the oncogenic splice isoform D1b is favoured over the splice isoform D1a <ref type="bibr" target="#b149">[150]</ref>. So far it remains unknown how many genes may be affected by this or a similar phenomenon.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.">EWS-FLI1 and Disrupted</head><p>Tumor Suppression. FET fusion proteins are aberrantly expressed transcription factors driving cell proliferation. As such they impose oncogenic stress on the cell triggering the p53 checkpoint <ref type="bibr">[151]</ref>. ESFT escape the oncogenic stress imposed by EWS-FLI1 by modulating p53 activity. Two mechanisms for this oncogenic property of EWS-FLI1 have recently been described: interference with tumor suppressive NOTCH signalling pathway activity through transcriptional regulation of autocrine NOTCH ligand expression <ref type="bibr" target="#b151">[152]</ref> and direct interaction with p53 <ref type="bibr" target="#b152">[153]</ref>. It should be noted, however, that the ability of EWS-FLI1 to modulate p53 activity is tissue dependent. In fibroblasts, EWS-FLI1 was demonstrated to elicit a p53-mediated cellcycle arrest <ref type="bibr">[151]</ref>. Most other cell types do not tolerate EWS-FLI1 expression at all and die in response to ectopic expression of the chimeric oncogene (for review <ref type="bibr" target="#b101">[102]</ref>). The only tissue permissive to the oncogenic properties of EWS-FLI1 identified so far is mesenchymal stem cells <ref type="bibr" target="#b102">[103]</ref>. The tissue-specific factors that steer the p53 response into the one (growth arrest/apoptosis) or the other (escape from oncogenic stress) direction remain to be elucidated.</p><p>There is also evidence for EWS-FLI1 interfering with the other central tumor suppressor pathway in oncogenesis: although the mechanism still remains to be defined, knockdown of EWS-FLI1 in ESFT cells leads to pRB-1 hypophosphorylation <ref type="bibr" target="#b153">[154]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Getting Hold of Mr. Hyde</head><p>The development of small molecule inhibitors of biological macromolecules, originally in the context of chromosome translocations, has been pioneered by research on receptor tyrosine kinases. Here, the design of smart molecules is guided primarily by crystallography and structure/function analyses of the target proteins. For FET fusion proteins, this approach is not feasible because of the intrinsic disorder of their structure. However, recent landmark studies provided proof of principle for successful interference with protein interactions of intrinsically disordered proteins <ref type="bibr" target="#b154">[155]</ref>. Guided by a peptide aptamer screen, a small molecule mimetic was described that competes with RNA helicase A for interaction with the EWS N-terminus in the context of the EWS-FLI1 fusion protein and slowed tumor formation in mice <ref type="bibr" target="#b155">[156]</ref>. There is evidence from protein interaction studies that the faces of the EWS N-terminus look different in the context of the wildtype protein (Dr. Jekyll) and the Sarcoma transcription factor fusion protein (Mr. Hyde) <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref>. Thus, there is hope that the evil culprit for the development and progression of several sarcomas and leukemias that is still hiding in the dark can be successfully targeted in the near future.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 :</head><label>2</label><figDesc>FET gene fusions in cancer. TF: transcription factor.</figDesc><table><row><cell>Phenotype</cell><cell>FET partner</cell><cell>TF partner</cell><cell>TF type</cell><cell>Ref.</cell></row><row><cell>ESFT</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(85%)</cell><cell>EWS</cell><cell>FLI1</cell><cell>ETS</cell><cell>[3]</cell></row><row><cell>(10%)</cell><cell>EWS</cell><cell>ERG</cell><cell>ETS</cell><cell>[82, 83]</cell></row><row><cell>(1%)</cell><cell>EWS</cell><cell>ETV1</cell><cell>ETS</cell><cell>[84]</cell></row><row><cell>(1%)</cell><cell>EWS</cell><cell>ETV4</cell><cell>ETS</cell><cell>[85, 86]</cell></row><row><cell>(1%)</cell><cell>EWS</cell><cell>FEV</cell><cell>ETS</cell><cell>[87]</cell></row><row><cell>(1%)</cell><cell>FUS</cell><cell>FEV</cell><cell>ETS</cell><cell>[25]</cell></row><row><cell>(1%)</cell><cell>FUS</cell><cell>ERG</cell><cell>ETS</cell><cell>[88]</cell></row><row><cell>ESFT-like</cell><cell>EWS</cell><cell>NFATC2</cell><cell>rel related</cell><cell>[89]</cell></row><row><cell>Askin-like, CD99 neg.</cell><cell>EWS</cell><cell>ZNF278</cell><cell>zinc finger</cell><cell>[90]</cell></row><row><cell>Bone sarcoma</cell><cell>EWS</cell><cell>POU5F1</cell><cell>pou</cell><cell>[91]</cell></row><row><cell>Mucoepidermoid carcinaoma</cell><cell>EWS</cell><cell>POU5F1</cell><cell>pou</cell><cell>[92]</cell></row><row><cell>Hidradenoma</cell><cell>EWS EWS</cell><cell>POU5F1 PBX1</cell><cell>pou homeobox</cell><cell>[92] [92]</cell></row><row><cell>Low-grade fibromyxoid sarcoma</cell><cell>FUS</cell><cell>CREB3L1</cell><cell>Leucine zipper</cell><cell>[93]</cell></row><row><cell>Myxoid liposarcoma</cell><cell>EWS</cell><cell>DDIT3</cell><cell>bZIP</cell><cell>[94]</cell></row><row><cell></cell><cell>FUS</cell><cell>DDIT3</cell><cell>bZIP</cell><cell>[5]</cell></row><row><cell>Clear cell sarcoma</cell><cell>EWS EWS</cell><cell>ATF1 CREB1</cell><cell>bZIP bZIP</cell><cell>[95] [96]</cell></row><row><cell>Desmoplastic SRCT</cell><cell>EWS</cell><cell>WT1</cell><cell>zinc finger</cell><cell>[97]</cell></row><row><cell>Extraskeletal myxoid chondrosarcoma</cell><cell>EWS TAF15</cell><cell>NR4A3 NR4A3</cell><cell>nuclear receptor nuclear receptor</cell><cell>[98] [99]</cell></row><row><cell>AML</cell><cell>FUS</cell><cell>ERG</cell><cell>ETS</cell><cell>[100]</cell></row><row><cell>cALL, AUL</cell><cell>EWS</cell><cell>ZNF384</cell><cell>zinc finger</cell><cell>[101]</cell></row><row><cell>AML, ALL</cell><cell>TAF15</cell><cell>TAF15</cell><cell>zinc finger</cell><cell>[101]</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>5805, 2011, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1155/2011/837474, Wiley Online Library on [04/03/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</p></note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">The Strange Case of Dr</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Stevenson</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1886">1886</date>
			<publisher>Penguin Books</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>St√•hlberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Arvidsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Cell Biology</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">37</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours</title>
		<author>
			<persName><forename type="first">O</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zucman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Plougastel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">359</biblScope>
			<biblScope unit="issue">6391</biblScope>
			<biblScope unit="page" from="162" to="165" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">A nuclear protein regulated during the transition from active to quiescent phenotype in cultured endothelial cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Alliegro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Alliegro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Developmental Biology</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="288" to="297" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma</title>
		<author>
			<persName><forename type="first">A</forename><surname>Crozat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Aman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mandahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="issue">6430</biblScope>
			<biblScope unit="page" from="640" to="644" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Rabbitts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Forster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nathan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genetics</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="175" to="180" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zinszner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Albalat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes and Development</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="2513" to="2526" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bertolotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Heard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chambon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tora</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO Journal</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="5022" to="5031" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Molecular cloning and subcellular localisation of the snRNP-associated protein 69KD, a structural homologue of the proto-oncoproteins TLS and EWS with RNA and RNA-binding properties</title>
		<author>
			<persName><forename type="first">W</forename><surname>Hackl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>L√ºhrmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Biology</title>
		<imprint>
			<biblScope unit="volume">264</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="843" to="851" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II</title>
		<author>
			<persName><forename type="first">D</forename><surname>Immanuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zinszner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="4562" to="4571" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Cabeza, a Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Stolow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Haynes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="835" to="843" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Analysis of Ewing Sarcoma (EWS)-binding proteins: interaction with hnRNP M, U, and RNA-helicases p68/72 within protein-RNA complexes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Pahlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Quero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Roschitzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Leemann-Zakaryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gehring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Proteome Research</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4455" to="4465" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Identification and characterization of the nuclear localization/retention signal in the EWS proto-oncoprotein</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Zakaryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gehring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Biology</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="27" to="38" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Conserved structures and diversity of functions of RNA-binding proteins</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Burd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dreyfuss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">265</biblScope>
			<biblScope unit="issue">5172</biblScope>
			<biblScope unit="page" from="615" to="621" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Identification of an RNA binding specificity for the potential splicing factor TLS</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lerga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hallier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Delva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="6807" to="6816" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ouchida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Gatalica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S P</forename><surname>Reddy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="3087" to="3097" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Identification of RNA binding specificity for the TET-family proteins</title>
		<author>
			<persName><forename type="first">K</forename><surname>Takahama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Arai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Symposium Series</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="213" to="214" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Arai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">454</biblScope>
			<biblScope unit="issue">7200</biblScope>
			<biblScope unit="page" from="126" to="130" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bailly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bosselut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zucman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="3230" to="3241" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The N-terminal domain of human TAF(II)68 displays transactivation and oncogenic properties</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bertolotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tora</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">56</biblScope>
			<biblScope unit="page" from="8000" to="8010" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene</title>
		<author>
			<persName><forename type="first">L</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A W</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">31</biblScope>
			<biblScope unit="page" from="4161" to="4168" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The hTAF68-TEC fusion protein functions as a strong transcriptional activator</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Jun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2446" to="2453" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D K</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ouchida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S P</forename><surname>Reddy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3717" to="3729" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly</title>
		<author>
			<persName><forename type="first">S</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Ming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Dunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A W</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1625" to="1631" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Ewing sarcoma with novel translocation t(2;16) producing an in-flame fusion of FUS and FEV</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>O'sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Pallen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Diagnostics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="459" to="463" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Transcriptional activation by the Ewing&apos;s sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A W</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="issue">30</biblScope>
			<biblScope unit="page" from="23053" to="23058" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains</title>
		<author>
			<persName><forename type="first">D</forename><surname>Alex</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A W</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Research</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1323" to="1331" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Single-chain antibodies to the EWS NH terminus structurally discriminate between intact and chimeric EWS in Ewing&apos;s sarcoma and interfere with the transcriptional activity of EWS in vivo</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N T</forename><surname>Aryee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kreppel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bachmaier</surname></persName>
		</author>
		<idno type="DOI">10.1155/2011/837474</idno>
		<idno>. 5805</idno>
		<ptr target="https://onlinelibrary.wiley.com/terms-and-conditions" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="9862" to="9869" />
			<date type="published" when="2006">2006. 2011, 1. 04/03/2025</date>
		</imprint>
	</monogr>
	<note>Creative Commons License Sarcoma 9</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the tet family, EWS and HTAF(II)68, and subunits of TFIID and RNA polymerase II complexes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bertolotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Melot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Acker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vigneron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tora</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1489" to="1497" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II</title>
		<author>
			<persName><forename type="first">R</forename><surname>Petermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Mossier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N T</forename><surname>Aryee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Khazak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Golemis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kovar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="603" to="610" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cooperative interaction of EWS with CREB-binding protein selectively activates hepatocyte nuclear factor 4-mediated transcription</title>
		<author>
			<persName><forename type="first">N</forename><surname>Araya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hirota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shimamoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="5427" to="5432" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Stimulation of Oct-4 activity by Ewing&apos;s sarcoma protein</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Rhee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Y</forename><surname>Bae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stem Cells</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="738" to="751" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Oncogenic serine-threonine kinase receptorassociated protein modulates the function of ewing sarcoma protein through a novel mechanism</title>
		<author>
			<persName><forename type="first">G</forename><surname>Anumanthan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Halder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Datta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="10824" to="10832" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-Œ∫B p65-mediated transcription as a coactivator</title>
		<author>
			<persName><forename type="first">H</forename><surname>Uranishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tetsuka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamashita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="13395" to="13401" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The pro-oncoprotein EWS (Ewing&apos;s Sarcoma protein) interacts with the Brn-3a POU transcription factor and inhibits its ability to activate transcription</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Latchman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Biology &amp; Therapy</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="428" to="432" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Cloning and characterization of human TAF20/15. Multiple interactions suggest a central role in TFIID complex formation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Roeder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="issue">30</biblScope>
			<biblScope unit="page" from="18194" to="18202" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">TLS (translocated-in-liposarcoma) is a highaffinity interactor for steroid, thyroid hormone, and retinoid receptors</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Powers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mathur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Raaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Samuels</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Endocrinology</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="4" to="18" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1</title>
		<author>
			<persName><forename type="first">R</forename><surname>Ramakrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Zou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">42</biblScope>
			<biblScope unit="page" from="7087" to="7094" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">The ewing sarcoma protein (EWS) binds directly to the proximal elements of the macrophage-specific promoter of the CSF-1 receptor (csf1r) gene</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Hume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sasmono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Himes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Immunology</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="6733" to="6742" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">TLS inhibits RNA polymerase III transcription</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Manley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="186" to="196" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Deloulme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Prichard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Storm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="issue">43</biblScope>
			<biblScope unit="page" from="27369" to="27377" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Chansky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Hickstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="3586" to="3590" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The splicing factor U1C represses EWS/FLI-mediated transactivation</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Knoop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Baker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="issue">32</biblScope>
			<biblScope unit="page" from="24865" to="24871" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">EWS‚Ä¢Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine proteinmediated RNA splicing</title>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Chansky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Hickstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="issue">48</biblScope>
			<biblScope unit="page" from="37612" to="37618" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins</title>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Embree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Hickstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="3345" to="3354" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing</title>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Embree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Hickstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">273</biblScope>
			<biblScope unit="issue">43</biblScope>
			<biblScope unit="page" from="27761" to="27764" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The transcriptional repressor, ZFM1 interacts with and modulates the ability of EWS to activate transcription</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Paley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Childs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">273</biblScope>
			<biblScope unit="issue">29</biblScope>
			<biblScope unit="page" from="18086" to="18091" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Intracellular characterization of DDX39, a novel growth-associated RNA helicase</title>
		<author>
			<persName><forename type="first">T</forename><surname>Sugiura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sakurai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nagano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Experimental Cell Research</title>
		<imprint>
			<biblScope unit="volume">313</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="782" to="790" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Toretsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Erkizan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Levenson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="5574" to="5581" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cevher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="4561" to="4565" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Kleiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Manley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="issue">5433</biblScope>
			<biblScope unit="page" from="1576" to="1579" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">The BARD1-CstF-50 interaction links mRNA 3 end formation to DNA damage and tumor suppression</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Kleiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Manley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="743" to="753" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Interaction of the EWS NH terminus with BARD1 links the Ewing&apos;s sarcoma gene to a common tumor suppressor pathway</title>
		<author>
			<persName><forename type="first">L</forename><surname>Spahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Petermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Siligan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N T</forename><surname>Aryee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kovar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="4583" to="4587" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">The Microprocessor complex mediates the genesis of microRNAs</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">I</forename><surname>Gregory</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Amuthan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">432</biblScope>
			<biblScope unit="issue">7014</biblScope>
			<biblScope unit="page" from="235" to="240" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Identification of novel genes coding for small expressed RNAs</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lagos-Quintana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rauhut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Lendeckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tuschl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">294</biblScope>
			<biblScope unit="issue">5543</biblScope>
			<biblScope unit="page" from="853" to="858" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Extensive posttranscriptional regulation of microRNAs and its implications for cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Thomson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Morin-Kensicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Hammond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes and Development</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="2202" to="2207" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Identification of a new coiled body component</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Alliegro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Alliegro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Experimental Cell Research</title>
		<imprint>
			<biblScope unit="volume">231</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="386" to="390" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zinszner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Immanuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="451" to="461" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Identification of hnRNP P2 as TLS/FUS using electrospray mass spectrometry</title>
		<author>
			<persName><forename type="first">C</forename><surname>Calvio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Neubauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Lamond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">RNA</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="724" to="733" />
			<date type="published" when="1995">1995</date>
			<publisher>Sarcoma</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zinszner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Immanuel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Cell Science</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1741" to="1750" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology</title>
		<author>
			<persName><forename type="first">R</forename><surname>Fujii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Okabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Urushido</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Biology</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="587" to="593" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines</title>
		<author>
			<persName><forename type="first">R</forename><surname>Fujii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takumi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Cell Science</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="5755" to="5765" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state</title>
		<author>
			<persName><forename type="first">S</forename><surname>Pahlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Zakaryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gehring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proteins</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1125" to="1137" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein</title>
		<author>
			<persName><forename type="first">L</forename><surname>Spahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Siligan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bachmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N T</forename><surname>Aryee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kovar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">44</biblScope>
			<biblScope unit="page" from="6819" to="6829" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">The Ewing&apos;s sarcoma protein interacts with the Tudor domain of the survival motor neuron protein</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Francis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lince</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Coon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Androphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Lorson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Brain Research</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="37" to="49" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Felsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Peralta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Biology</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="485" to="488" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Transcriptional down-regulation through nuclear exclusion of EWS methylated by PRMT1</title>
		<author>
			<persName><forename type="first">N</forename><surname>Araya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hiraga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kako</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Arao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fukamizu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<imprint>
			<biblScope unit="volume">329</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="653" to="660" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Expression and subcellular localization of Ewing sarcoma (EWS) protein is affected by the methylation process</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Belyanskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gehring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Experimental Cell Research</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="374" to="381" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Different methylation characteristics of protein arginine methyltransferase 1 and 3 toward the Ewing Sarcoma protein and a peptide</title>
		<author>
			<persName><forename type="first">S</forename><surname>Pahlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bschir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chiavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Belyanskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gehring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proteins</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="164" to="175" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">EWS is a substrate of type I protein arginine methyltransferase, PRMT8</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kako</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kakiuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fukamizu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Molecular Medicine</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="309" to="315" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Identification of a self-association domain in the Ewing&apos;s sarcoma protein: a novel function for arginineglycine-glycine rich motifs?</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Morse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Todd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Eggleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Lorson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Young</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biochemistry</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="885" to="893" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Identification of a tripartite import signal in the Ewing Sarcoma protein (EWS)</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Morse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Todd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Eggleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Lorson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Young</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<imprint>
			<biblScope unit="volume">390</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1197" to="1201" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Exposure on cell surface and extensive arginine methylation of EWS protein</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Belyanskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Gehrig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gehring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="18681" to="18687" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Hicks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nashabi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genetics</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="175" to="179" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development</title>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Watford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1314" to="1323" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Ewing sarcoma protein Ewsr1 maintains mitotic integrity and proneural cell survival in the zebrafish embryo</title>
		<author>
			<persName><forename type="first">M</forename><surname>Azuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Embree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sabaawy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Hickstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">10</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>Article ID e979</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF(II)68 proteins</title>
		<author>
			<persName><forename type="first">O</forename><surname>Guipaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Guillonneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Labas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proteomics</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="5962" to="5972" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">A topoisomerase IIŒ≤mediated dsDNA break required for regulated transcription</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">V</forename><surname>Lunyak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Perissi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">312</biblScope>
			<biblScope unit="issue">5781</biblScope>
			<biblScope unit="page" from="1798" to="1802" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Kwiatkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Bosco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Leclerc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="issue">5918</biblScope>
			<biblScope unit="page" from="1205" to="1208" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6</title>
		<author>
			<persName><forename type="first">C</forename><surname>Vance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rogelj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hortob√°gyi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="issue">5918</biblScope>
			<biblScope unit="page" from="1208" to="1211" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">ALS-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to coregulate HDAC6 mRNA</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shanware</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Bowler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="issue">44</biblScope>
			<biblScope unit="page" from="34097" to="34105" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">A second Ewing&apos;s sarcoma translocation, t(21;22), fuses the EWS gene to another ETSfamily transcription factor, ERG</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H B</forename><surname>Sorensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lessnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lopez-Terrada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">F</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Triche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Denny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genetics</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="146" to="151" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Combinatorial generation of variable fusion proteins in the Ewing family of tumours</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zucman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Melot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Desmaze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO Journal</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="4481" to="4487" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">A variant Ewing&apos;s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Braun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1229" to="1234" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Fusion of an ETSfamily gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kaneko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Handa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes and Cancer</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="115" to="121" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">F</forename><surname>Urano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Umezawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kikuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Hata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<imprint>
			<biblScope unit="volume">219</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="608" to="612" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">A new member of the ETS family fused to EWS in Ewing tumors</title>
		<author>
			<persName><forename type="first">M</forename><surname>Peter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Couturier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pacquement</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1159" to="1164" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">FUS/ERG gene fusions in Ewing&apos;s tumors</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Shing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Mcmullan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roberts</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="4568" to="4576" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">The NFATc2 Gene is involved in a novel cloned translocation in a ewing sarcoma variant that couples its function in immunology to oncology</title>
		<author>
			<persName><forename type="first">K</forename><surname>Szuhai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ijszenga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">De</forename><surname>Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Karseladze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Tanke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C W</forename><surname>Hogendoorn</surname></persName>
		</author>
		<idno type="DOI">10.1155/2011/837474</idno>
		<idno>. 5805</idno>
		<ptr target="https://onlinelibrary.wiley.com/terms-and-conditions" />
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2259" to="2268" />
			<date type="published" when="2009">2009. 2011, 1. 04/03/2025</date>
		</imprint>
	</monogr>
	<note>Creative Commons License Sarcoma 11</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">A novel zinc finger gene is fused to EWS in small round cell tumor</title>
		<author>
			<persName><forename type="first">T</forename><surname>Mastrangelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Modena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tornielli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">33</biblScope>
			<biblScope unit="page" from="3799" to="3804" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22) (p21;q12)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Yamaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mukai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes and Cancer</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="217" to="222" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">POU5FI, encoding a key regulator of stem cell pluripotency, is fused to EWSRI in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands</title>
		<author>
			<persName><forename type="first">E</forename><surname>M√∂ller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stenman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mandahl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Pathology</title>
		<imprint>
			<biblScope unit="volume">215</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="78" to="86" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mertens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D M</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Antonescu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Laboratory Investigation</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="408" to="415" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Fusion of the EWS and CHOP genes in myxoid liposarcoma</title>
		<author>
			<persName><forename type="first">I</forename><surname>Panagopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>H√∂glund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mertens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mandahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mitelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>√Öman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="489" to="494" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zucman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Delattre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Desmaze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genetics</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="341" to="345" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">EWS-CREB1: a recurrent variant fusion in clear cell sarcoma-association with gastrointestinal location and absence of melanocytic differentiation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Antonescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nafa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Segal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dal Cin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ladanyi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="5356" to="5362" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ladanyi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Gerald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2837" to="2840" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Labelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zucman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stenman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Human Molecular Genetics</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2219" to="2226" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sj√∂gren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Meis-Kindblom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Kindblom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>√Öman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stenman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="5064" to="5067" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22)</title>
		<author>
			<persName><forename type="first">I</forename><surname>Panagopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Aman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fioretos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes and Cancer</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="256" to="262" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Recurrent rearrangement of the Ewing&apos;s sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia</title>
		<author>
			<persName><forename type="first">A</forename><surname>Martini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>La</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Starza</surname></persName>
		</author>
		<author>
			<persName><surname>Janssen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="5408" to="5412" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Context matters: the hen or egg problem in Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kovar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Seminars in Cancer Biology</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="189" to="196" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Development of Ewing&apos;s sarcoma from primary bone marrow-derived mesenchymal progenitor cells</title>
		<author>
			<persName><forename type="first">N</forename><surname>Riggi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cironi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Provero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="11459" to="11468" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Teitell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H B</forename><surname>Sorensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shimada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Triche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Denny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Laboratory Investigation</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1535" to="1543" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Divergent Ewing&apos;s sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Teitell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arvand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Denny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">40</biblScope>
			<biblScope unit="page" from="5506" to="5513" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sj√∂gren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Meis-Kindblom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Kindblom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>√Öman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stenman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="5064" to="5067" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fukuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Okita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Hata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Umezawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein</title>
		<author>
			<persName><forename type="first">E</forename><surname>Beauchamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bulut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Abaan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="9074" to="9082" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors</title>
		<author>
			<persName><forename type="first">J</forename><surname>Joo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Warner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">7608</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">B</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Inwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Janknecht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1344" to="1353" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">VEGF promotes the osteolytic bone destruction of ewing&apos;s sarcoma tumors by upregulating RANKL</title>
		<author>
			<persName><forename type="first">H</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Kleinerman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncology Research</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">2-3</biblScope>
			<biblScope unit="page" from="117" to="125" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">EWS-FLI1 target genes recovered from Ewing&apos;s sarcoma chromatin</title>
		<author>
			<persName><forename type="first">C</forename><surname>Siligan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bachmaier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="2512" to="2524" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Ewing&apos;s sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5 promoter</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kikuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Murakami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sobue</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1802" to="1810" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing&apos;s Sarcoma tumorigenesis</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Abaan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Levenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Furth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>√úren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Toretsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="2715" to="2722" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing&apos;s sarcoma cells</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Tirado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mateo-Lozano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Villar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="9937" to="9947" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing&apos;s sarcoma oncogenesis and therapeutic resistance</title>
		<author>
			<persName><forename type="first">W</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gangwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sankar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Boucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lessnick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">46</biblScope>
			<biblScope unit="page" from="4126" to="4132" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kinsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lessnick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Cancer Research</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="851" to="859" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mendiola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Carrillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Garc√≠a</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1381" to="1389" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kinsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Iyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R B</forename><surname>Mccabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lessnick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="9047" to="9055" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Sarcoma</note>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H S</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Plehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fasan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="5324" to="5329" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">EWS-Fli1 upregulates expression of the aurora A and aurora B kinases</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wakahara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Cancer Research</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1937" to="1945" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Induction of tenascin-C by tumor-specific EWS-ETS fusion genes</title>
		<author>
			<persName><forename type="first">G</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nishimori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Irifune</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes and Cancer</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="224" to="232" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Hahm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genetics</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="222" to="227" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Identification of p21 as a direct target of EWS-Fli1 oncogenic fusion protein</title>
		<author>
			<persName><forename type="first">F</forename><surname>Nakatani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sakimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="15105" to="15115" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3</title>
		<author>
			<persName><forename type="first">A</forename><surname>Prieur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tirode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Delattre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="7275" to="7283" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Benini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zuntini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Manara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1039" to="1046" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing&apos;s sarcoma cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zielinska-Kwiatkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Chansky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<imprint>
			<biblScope unit="volume">402</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="129" to="134" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">EWS/ETS regulates the expression of the Dickkopf family in Ewing family tumor cells</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Miyagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Okita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Itagaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">4634</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes Œ≤-catenin/TCF-mediated transcription</title>
		<author>
			<persName><forename type="first">D</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Agra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">√Å</forename><surname>Pesta√±a</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Alonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gonz√°lez-Sancho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="394" to="401" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Hancock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lessnick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="250" to="256" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">A molecular function map of Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kofler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">5415</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Mesenchymal stem cell features of Ewing tumors</title>
		<author>
			<persName><forename type="first">F</forename><surname>Tirode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Laud-Duval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Prieur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Delorme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Charbord</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Delattre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="421" to="429" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells</title>
		<author>
			<persName><forename type="first">N</forename><surname>Riggi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Suv√†</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">De</forename><surname>Vito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes and Development</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="916" to="932" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">EWS-FLI-1 expression triggers a ewing&apos;s sarcoma initiation program in primary human mesenchymal stem cells</title>
		<author>
			<persName><forename type="first">N</forename><surname>Riggi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Suv√†</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Suv√†</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2176" to="2185" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="8968" to="8975" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular Cancer Research</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="862" to="872" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">The Ewing&apos;s sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation</title>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Mcgee-Lawrence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Decker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Cellular Biochemistry</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="933" to="943" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">TEThered to Runx: novel binding partners for runx factors</title>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Decker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Westendorf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Cells, Molecules, and Diseases</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="82" to="85" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Owen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Kowalewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lessnick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>Article ID e1965</note>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Downstream EWS/FLI1-upstream Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kovar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Medicine</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Microsatellites are EWS/FLI response elements: genomic &quot;junk&quot; is EWS/FLI&apos;s treasure</title>
		<author>
			<persName><forename type="first">K</forename><surname>Gangwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lessnicke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="3127" to="3132" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Microsatellites as EWS/FLI response elements in Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">K</forename><surname>Gangwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sankar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Hollenhorst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">29</biblScope>
			<biblScope unit="page" from="10149" to="10154" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function</title>
		<author>
			<persName><forename type="first">N</forename><surname>Guillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tirode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Boeva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zynovyev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Barillot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Delattre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">4932</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Dax1 binds to Oct3/4 and inhibits its transcriptional activity in embryonic stem cells</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakatake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Akagi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="4574" to="4583" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">A protein interaction network for pluripotency of embryonic stem cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">444</biblScope>
			<biblScope unit="issue">7117</biblScope>
			<biblScope unit="page" from="364" to="368" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Multiple domains mediate transformation by the Ewing&apos;s sarcoma EWS/FLI-1 fusion gene</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lessnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Braun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Denny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>May</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="423" to="431" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jaishankar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Roussel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Baker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">40</biblScope>
			<biblScope unit="page" from="5592" to="5597" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Welford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Hebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Deneen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arvand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Denny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="issue">45</biblScope>
			<biblScope unit="page" from="41977" to="41984" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">EWS/FLI alters 5 -splice site selection</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Knoop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Baker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="issue">25</biblScope>
			<biblScope unit="page" from="22317" to="22322" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer</title>
		<author>
			<persName><forename type="first">G</forename><surname>Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bittencourt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Laud</surname></persName>
		</author>
		<idno type="DOI">10.1155/2011/837474</idno>
		<idno>. 5805</idno>
		<ptr target="https://onlinelibrary.wiley.com/terms-and-conditions" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="6004" to="6009" />
			<date type="published" when="2008">2008. 2011, 1. 04/03/2025</date>
		</imprint>
	</monogr>
	<note>Creative Commons License Sarcoma 13</note>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">EWS-FLI1 suppresses NOTCH-activated p53 in Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Bennani-Baiti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="7100" to="7109" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing family tumors</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Fan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Letters</title>
		<imprint>
			<biblScope unit="volume">294</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="57" to="65" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing family tumors</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Fan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Letters</title>
		<imprint>
			<biblScope unit="volume">294</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="57" to="65" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing&apos;s sarcoma cells</title>
		<author>
			<persName><forename type="first">H.-M</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zielinska-Kwiatkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Munro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Orthopaedic Research</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="886" to="893" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main">Intrinsically disordered proteins are potential drug targets</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Metallo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Chemical Biology</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="481" to="488" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main">A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">V</forename><surname>Erkizan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Merchant</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Medicine</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="750" to="756" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
